Welcome to our dedicated page for VSEE HEALTH SEC filings (Ticker: VSEEW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VSEE HEALTH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VSEE HEALTH's regulatory disclosures and financial reporting.
VSEE Health, Inc. received an amended Schedule 13G/A from a group led by Dominion Capital and Ascent Partners reporting reduced beneficial ownership of its common stock. The group now beneficially owns 1,014,654 shares, or about 2.97% of the company, based on 33,193,140 shares outstanding as of December 26, 2025.
The position includes 100,000 shares issued as closing shares under a March 20, 2025 promissory note and common stock purchase warrants exercisable for additional shares. The filers state this is an exit filing because they no longer own more than 5% and certify the holdings are not for control purposes.